Internal Medicine, Infectious Disease · Green Bay, WI
NPI
1871720995
Since 2009
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
1715 Dousman St
Green Bay, WI, 54303
Phone (920) 496-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
709 services
Medicare patients, 2024
190
Average age 72
Drug cost, 2024
$1.1M
1,579 prescriptions
Company payments, 2023
$16.11
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Agnes K Kresch was code 99214 (office e&m - established), 138 times for 67 patients. In total Agnes K Kresch billed 709 services in 30 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 138 | 67 | $94.34 | $13K |
| 99223 Hospital E&M - Initial | Facility | 72 | 69 | $126.31 | $9,094 |
| 85025 Blood Count | Office | 70 | 33 | $7.61 | $533 |
| 36415 Venipuncture Blood Collection | Office | 67 | 37 | $8.53 | $571 |
| 85652 Clinical Chemistry | Office | 65 | 29 | $2.65 | $172 |
| 99233 Hospital E&M - Subsequent | Facility | 56 | 40 | $87.50 | $4,900 |
| 81001 Clinical Chemistry | Office | 50 | 12 | $3.11 | $156 |
| 99443 Telephone Services | Office | 42 | 24 | $90.13 | $3,786 |
| 99232 Hospital E&M - Subsequent | Facility | 29 | 21 | $61.39 | $1,780 |
| 99222 Hospital E&M - Initial | Facility | 24 | 22 | $101.63 | $2,439 |
| 99215 Office E&M - Established | Office | 20 | 18 | $135.03 | $2,701 |
| 99213 Office E&M - Established | Office | 17 | 14 | $64.33 | $1,094 |
| 99205 Office E&M - New | Office | 16 | 16 | $160.05 | $2,561 |
By year: 2022 $35K for 593 services; 2023 $36K for 519 services; 2024 $45K for 709 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 70 | 33 | $7.61 | $533 |
| 36415 Venipuncture Blood Collection | 67 | 37 | $8.53 | $571 |
| 85652 Clinical Chemistry | 65 | 29 | $2.65 | $172 |
| 81001 Clinical Chemistry | 50 | 12 | $3.11 | $156 |
Medicare prescription drug claims, 2024
In 2024, the drug Agnes K Kresch prescribed most often to Medicare patients was Doxycycline Hyclate, with 120 prescriptions and refills. In total Agnes K Kresch wrote 1,579 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 120 | 186 | 47 | $5,735 |
| Ertapenem Ertapenem Sodium | 87 | 87 | Under 11 | $43K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 81 | 81 | 11 | $311K |
| Daptomycin Generic | 69 | 69 | Under 11 | $187K |
| Cefdinir Generic | 65 | 79 | 35 | $3,182 |
| Cephalexin Generic | 61 | 107 | 22 | $1,164 |
| Ceftriaxone Ceftriaxone Sodium | 49 | 49 | 11 | $5,755 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 47 | 85 | 20 | $1,190 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 42 | 60 | 19 | $1,612 |
| Fluconazole Generic | 39 | 64 | 16 | $1,356 |
| Vancomycin Hcl Generic | 37 | 39 | 13 | $6,229 |
| Levofloxacin Generic | 32 | 40 | 13 | $352 |
| Moxifloxacin Hcl Generic | 31 | 32 | Under 11 | $6,714 |
| Meropenem Generic | 30 | 30 | Under 11 | $11K |
| Ciprofloxacin Hcl Generic | 27 | 31 | 11 | $490 |
Brand drugs: - claims; generic drugs: 1,249 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Agnes K Kresch $16.11 ($16.11 in general payments such as food, travel and fees) from 1 company. The largest payer was Nestle Healthcare Nutrition Inc. with $16.11.
| Company | Payments | Amount |
|---|---|---|
| Nestle Healthcare Nutrition Inc. | 1 | $16.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.